
Scott Lee
Director, Clinical Inflammatory Bowl Disease Program, UW Medicine · University of Washington School of Medicine
Credentials: · · ·
History
Research
Vedolizumab as induction and maintenance therapy for Crohn's disease
New England Journal of Medicine · 2013 · 1,750 citations
Ustekinumab as Induction and Maintenance Therapy for Crohn's Disease
New England Journal of Medicine · 2016 · 1,543 citations
Clinical Gastroenterology and Hepatology · 2013 · 371 citations

19 papers

15 papers · 11 as a resident

7 papers

7 papers

7 papers

6 papers

6 papers
- JJ
6 papers · 1 as a fellow
Clinical trials
- 2010–2021
Study of Cimzia for the Treatment of Ulcerative Colitis
Principal investigator · Completed · Phase 2
University of Washington
- 2008–2020
Induction of Clinical Response Using Rifaximin in Crohn's Disease
Principal investigator · Completed · Phase 2
Scott Lee
- 2003–2007
Asacol Dosing Study for Active Ulcerative Colitis
Principal investigator · Completed · Phase 4
University of Washington






